Skip to content
healthcare.dev

Nadolol

NDC 69097-869, Nadolol, tablet, from Cipla USA Inc..

Product NDC
69097-869
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203455
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-869 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NADOLOL80 mg/1

Pharmacologic classes

Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
69097-869-026909708690230 TABLET in 1 BOTTLE (69097-869-02)
69097-869-0769097086907100 TABLET in 1 BOTTLE (69097-869-07)
69097-869-15690970869151000 TABLET in 1 BOTTLE (69097-869-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c899eedb-4113-45da-acc3-8e181250a7d8

Use it

Look up 69097-869 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-869 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-869. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.